Perceptive Inc. is hosting a webinar featuring Julian Goggi, PhD, to explore the science behind RLT combination strategies and translational tools for evaluating them.
Public source
Publisher name
Public post
Radioligand therapy combinations have the potential to improve therapeutic response, but selecting the right combination, model and dosing strategy is critical. Now avai…
Company
Perceptive Inc.
Delivering Discovery, eClinical, and Imaging Solutions to the Global Biopharmaceutical Industry
- Industry
- Biotechnology Research
- Location
- London, GB
- Company size
- 1,001–5,000 employees
About Perceptive Inc.
Expanding on their combined 50-year history, Perceptive provides best-in-class specialist support to global pharmaceutical, biotech, and clinical research organizations, spanning the complete R&D lifecycle, from discovery and preclinical through clinical development to post marketing. Perceptive’s offerings include imaging biomarkers and core lab services, as well as innovative technologies in randomization and trial supply management (RTSM), analytics, and software.
See moreLatest activity
Latest activity from Perceptive Inc.
19 signals
Research & Knowledge
Perceptive Inc. published an analysis examining site-central discordance across a large dataset of solid tumor clinical trials led by Greg Goldmacher, MD, PhD, now Chief Scientific & Medical Officer.
Research & Knowledge
Perceptive Inc. published a paper titled Site/central discordance in oncology trials on site/central discordance in oncology trials.
Presence & Recognition
Perceptive Inc. is hosting a webinar featuring Julian Goggi, PhD, to explore the science behind RLT combination strategies and translational tools for evaluating them.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Champions Oncology, Inc.
Champions Oncology, Inc. is hosting a live webinar on September 29, 2026, featuring Professor Henry VanBrocklin and Denis Beckford discussing radiopharmaceuticals, models, and translational strategies.
Presence & Recognition
Quanterix
Quanterix is hosting a virtual webinar on September 15 at 11 a.m. ET to explore biomarker operations and clinical trial enrichment.
Presence & Recognition
Franklin Biolabs
Franklin Biolabs is hosting a webinar titled Building Robust Potency Assays with In-Cell Western™ Assay Protein Expression Readouts on September 3, 2026, to learn practical approaches for developing reliable, quantitative potency measurements using protein expression readouts.
Presence & Recognition
Sygnature Discovery
Sygnature Discovery's Gavin Milne will join guest speaker Prashant Desai (Genentech) and Optibrium CEO Matthew Segall for the upcoming webinar on metabolism in discovery.
Presence & Recognition
IDDI